Related Experiment Video
Updated: Mar 6, 2026
09:43
Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
12.6K
HFE mutations and iron in hemodialysis patients
1Department of Pathophysiology and Transplantation, Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy.
Hemodialysis International. International Symposium on Home Hemodialysis
|March 16, 2017
Summary
Genetic factors influencing iron metabolism in hemodialysis patients may improve anemia control and reduce mortality. Mutations in the HFE gene appear beneficial by lowering hepcidin levels, enhancing iron availability for red blood cell production.
Area of Science:
- Nephrology
- Genetics
- Hematology
Background:
- Chronic hemodialysis patients often exhibit disrupted iron metabolism, leading to deficiency and iron sequestration in macrophages.
- Chronic inflammation frequently elevates hepcidin, a hormone that impairs iron absorption and erythron availability.
- Understanding genetic influences on iron metabolism is crucial for managing anemia in this population.
Purpose of the Study:
- To systematically review the literature on genetic risk factors affecting iron metabolism in hemodialysis patients.
- To explore the potential benefits of specific genetic mutations, such as in the HFE gene, on iron availability and anemia management.
- To investigate the role of other genetic determinants, like TMPRSS6 variants, in modulating iron status.
Main Methods:
- Systematic literature review focusing on genetic factors and iron metabolism in hemodialysis.
- Analysis of studies examining HFE gene mutations and their impact on hepcidin levels and erythropoiesis.
- Inclusion of research on other genetic variants influencing iron status, such as TMPRSS6.
Main Results:
- HFE gene mutations associated with hereditary hemochromatosis may offer an adaptive advantage by reducing hepcidin, thereby improving iron availability for erythropoiesis.
- This genetic influence can enhance anemia control, response to erythropoiesis-stimulating agents and iron therapy, and potentially reduce treatment side effects.
- Variants in genes like TMPRSS6 also impact iron metabolism, likely through hepcidin regulation.
Conclusions:
- Genetic factors, particularly HFE mutations, may favorably alter iron metabolism in hemodialysis patients, improving anemia management and potentially reducing mortality from cardiovascular and infectious diseases.
- The HFE protein and Transferrin receptor-2 might directly influence erythroid differentiation and iron uptake.
- Further genetic research is essential for personalized clinical management and developing novel therapeutic strategies.
Related Concept Videos
01:24Hemodialysis II: Procedure and Complications
1.3K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.3K
01:25Hemodialysis I: Introduction
2.5K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.5K
01:25Hemodialysis III: Nursing Management
1.3K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.3K
01:25Peritoneal Dialysis III: Nursing Management
1.2K
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.2K
01:24Chronic Kidney Disease II: Clinical Manifestations
835
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
835
01:28Chronic Kidney Disease III: Interprofessional Care
558
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558